Valeant to Acquire Sprout and Enter Sexual Health Market

24.08.2015 - US specialty drugs company Valeant Pharmaceuticals has agreed to pay $1 billion in cash, on a debt-free basis, for female sexual heath firm Sprout Pharmaceuticals. Under the terms...